Molbio Diagnostics IPO: Key Details For Retail Investors In A ₹7,443 Crore Week

Nidhi Thakur

August 9, 2026

Key Takeaways

Five IPOs are launching next week across India, led by Molbio Diagnostics IPO, totaling ₹7,443 crore.
Dhoot Transmission is the largest at ₹3,067 crore, with a price band of ₹829-871 per share.
Milky Mist Dairy Food opens on August 11 with ₹1,553 crore size and a price band of ₹133-140.
Use of proceeds across all five IPOs include expansion, capex, debt repayment and other corporate purposes.

Five IPOs are launching next week across India, led by Molbio Diagnostics IPO, with a combined aim to raise ₹7,443 crore across all five issues. The lineup includes Dhoot Transmission, Shiprocket, Milky Mist Dairy Food, Molbio Diagnostics, and Behari Lal Engineering. They span open dates from August 10 to August 12, with a mix of fresh issues and OFS components and proceeds earmarked for expansion, capex, debt repayment and other corporate purposes.

Here’s a quick snapshot of each issue, followed by a comparative table to help you assess the relative size, pricing and open dates.

Molbio Diagnostics IPO Key Details, Use Of Proceeds And Backers

The Molbio Diagnostics IPO is sized at ₹904-940 crore; the price band is ₹768-807 per share. The issue comprises a fresh issue of up to ₹200 crore and an OFS of up to 91.66 lakh shares. Backers include Temasek and Motilal Oswal Private Equity, with anchor investor IFC committing ₹20 crore. The company is Goa-based and has returned to the mainboard IPO market with strong anchor and secondary support, reflecting a broader confidence in healthcare tech diagnostics.

Proceeds across the five IPOs are earmarked for growth initiatives including business expansion, capital expenditure, debt repayment and other corporate purposes. Secondary market activity has seen significant participation by leading AIFs and institutional investors in Molbio Diagnostics share price related trading at ₹807 per share in secondary, highlighting robust demand in select strata of the investor community.

Investors can explore more about Molbio Diagnostics IPO details and compare with peers using Swastika's Sarthi AI stock assistant. Swastika's Sarthi AI stock assistant offers institutional-grade insights for retail investors.

Company	IPO Size (₹ crore)	Price Band (₹)	Open Date	Fresh Issue (₹ crore)	OFS
Dhoot Transmission	₹3,067	₹829-871	Aug 10	₹1,400	Up to 1.91 crore shares
Molbio Diagnostics	₹904-940	₹768-807	Aug 10	₹200	Up to 91.66 lakh shares
Milky Mist Dairy Food	₹1,553	₹133-140	Aug 11	₹1,428	Up to ₹125 crore
Shiprocket	₹1,617.5	₹92-97	Aug 12	₹885.50	Up to ₹732 crore
Behari Lal Engineering	₹302	₹271-285	Aug 12	₹93	Up to 73.20 lakh shares

In terms of sector distribution, Molbio Diagnostics sits at the intersection of healthcare and diagnostics, a space that has attracted long-term investor interest for its growth potential and defensive characteristics. The open dates for the broader five-IPO week span August 10 to August 12, with Molbio Diagnostics and Dhoot Transmission opening on August 10, Milky Mist Dairy Food on August 11, and Shiprocket plus Behari Lal Engineering on August 12.

Milky Mist IPO: Size, Price Band, And OFS Structure

Milky Mist Dairy Food's IPO size is ₹1,553 crore with a price band of ₹133-140 per share. The issue comprises a fresh issue of up to ₹1,428 crore and an OFS of up to ₹125 crore. The August 11 opening date makes it a key dairy sector IPO of the season and a bellwether for consumer staples exposure in Indian markets.

Download App Now

Dhoot Transmission IPO: Size, Band, OFS, And Promoter Background

Dhoot Transmission commands ₹3,067 crore in size, with a price band of ₹829-871 per share. The issue includes a fresh issue of up to ₹1,400 crore and an OFS of up to 1.91 crore shares. Promoters are BC Asia Investments XV Ltd, an entity of Bain Capital, and Mangalam Capital Private Ltd, bringing a private equity-backed track record to the offering.

Shiprocket IPO: Fresh Issue, OFS And Open Date For Retail Investors

Shiprocket's IPO totals ₹1,617.5 crore, with a price band of ₹92-97 per share. The issue comprises a fresh issue of up to ₹885.50 crore and an OFS of up to ₹732 crore by existing shareholders including Lightrock, Tribe Capital, and Moore Strategic Ventures. Open date is August 12, and the company operates in the logistics and e-commerce fulfillment space, a sector with strong growth tailwinds.

Download App Now

Behari Lal Engineering IPO: Fresh Issue, OFS, And Open Date

Behari Lal Engineering is sized at ₹302 crore with a price band of ₹271-285 per share. The issue comprises a fresh issue up to ₹93 crore and an OFS of up to 73.20 lakh shares by existing shareholders. Open date is August 12, opening opportunities for retail investors to participate in a mid-cap engineering offering.

Five IPOs To Raise ₹7,443 Crore: What It Means For Retail Investors

The primary market activity marks a sizable wave, with a total size of ₹7,443 crore across five IPOs. The mix covers healthcare tech (Molbio Diagnostics), logistics/tech (Shiprocket), dairy consumer (Milky Mist), power transmission (Dhoot Transmission), and engineering (Behari Lal Engineering). For retail investors, the key takeaway is to align valuation with business fundamentals, understand use of proceeds, and stay mindful of post-listing volatility.

Frequently Asked Questions

Which five companies are launching IPOs next week?

Dhoot Transmission, Shiprocket, Milky Mist Dairy Food, Molbio Diagnostics, and Behari Lal Engineering.

What is the total size across these five IPOs?

₹7,443 crore.

When do the IPOs open for subscription?

Molbio Diagnostics and Dhoot Transmission open on August 10; Milky Mist Dairy Food opens on August 11; Shiprocket and Behari Lal Engineering open on August 12.

What is the price band for Molbio Diagnostics IPO?

₹768-807 per share; Fresh issue up to ₹200 crore; OFS up to 91.66 lakh shares; Anchor investor IFC invested ₹20 crore; Backed by Temasek and Motilal Oswal Private Equity.

Which IPO is the largest in size among these five?

Dhoot Transmission IPO at ₹3,067 crore.

Conclusion

Retail investors now face a week of decisive IPOs across several growth-oriented sectors. The key is to map price bands and open dates to the underlying business fundamentals and the company’s ability to deploy proceeds efficiently. This is a moment to adopt a disciplined approach: identify the best risk-adjusted opportunities, verify anchor support and liquidity signals, and avoid chasing bids just because a stock is in a hot issue queue. Apply a simple mental model: compare post-issue valuation to the growth trajectory implied by the use of proceeds and management guidance, and layer in your risk tolerance before applying.

Open your trading and demat account here

Reference :

1 : Business Standard

DISCLAIMER:

^{The information contained herein are strictly confidential and are meant solely for the information of the recipient and shall not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written permission of Swastika Investmart Ltd. (“SIL”). The contents of this document are for information purpose only. This document is not an investment advice and must not alone be taken as the basis for an investment decision. Before taking any decision to invest, the recipient of this document must read carefully the Red Herring Prospectus (“RHP”) issued to know the details of IPO and various risks and uncertainties associated with the investment in the IPO of the Company. All recipients of this document must before acting on the given information/details, make their own investigation and apply independent judgment based on their specific investment objectives and financial position. They can also seek appropriate professional advice from their own legal and tax consultants, advisors, etc. to understand the risks and investment considerations arising from such investment. The investor should possess appropriate resources to analyze such investment and the suitability of such investment to such investor’s particular circumstances before making any decisions on the investment. The Investor shall be solely responsible for any action taken based on this document. SIL shall not be liable for any direct or indirect losses arising from the use of the information contained in this document and accept no responsibility for statements made otherwise issued or any other source of information received by the investor and the investor would be doing so at his/her/its own risk. The information contained in this document should not be construed as forecast or promise or guarantee or assurance of any kind. The investors are not being offered any assurance or guaranteed or fixed returns on their investments. The users of this document must bear in mind that past performances if any, are not indicative of future results. The actual returns on investment may be materially different than the past. Investments in Securities market products and instruments including in the IPO of the Company are highly risky and they are generally not an appropriate avenue for someone with limited resources/ limited investment and low risk tolerance. Such Investments are subject to market risks including, without limitation, price, volatility and liquidity and capital risks. Therefore, the users of this document must carefully consider all the information given in the RHP including the risks factors before making any investment in the Equity Shares of the Company.Swastika Investmart Ltd or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither Swastika Investmart Ltd nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. Swastika Investment Ltd may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any compensation/benefits from the Subject Company or third party in connection with the Research Report.CORPORATE & ADMINISTRATIVE OFFICE - 48, Jaora Compound, M.Y.H. Road, Indore - 452 001 | Phone 0731 - 6644000 Compliance Officer: Dimple Soni. Email: compliance@swastika.co.in Phone: (0731) 6644 241 Swastika Investmart Limited, SEBI Reg. No. : NSE/BSE/MSEI: INZ000192732 Merchant Banking: INM000012102 Investment Adviser: INA000009843 MCX/NCDEX: INZ000072532 CDSL/NSDL: IN-DP-115-2015 RBI Reg. No.: B-03-00174 IRDA Reg. No.: 713. Research Analyst Registration Number: INH000024073}